Mark Nicolls
Academic Appointments
- Associate Professor, Medicine - Pulmonary & Critical Care Medicine
- Member, Child Health Research Institute
Key Documents
Contact Information
-
Clinical Offices
Chest Clinic 300 Pasteur Dr A283 MC 5351 Stanford, CA 94305 Tel Work (650) 725-7061 Fax (650) 498-6288
- Academic Offices
Personal Information EmailNot for medical emergencies or patient use
Professional Overview
Clinical Focus
- Pulmonary Critical Care
- Lung Transplantation
- Heart-Lung Transplantation
- Transplantation Immunology
- Pulmonary Hypertension
- Pulmonary Disease
Administrative Appointments
- Chief, Pulmonary and Critical Care Medicine (2010 - present)
- Program Director, Pulmonary and Critical Care Fellowship (2009 - 2010)
- Faculty, Vera Moulton Wall Center For Pulmonary Vascular Disease (2007 - present)
- Member, Stanford Cardiovascular Institute (2007 - present)
- Director, Lung Immunology (2007 - present)
- Joint Appointment, Immunology & Rheumatology (2007 - present)
Professional Education
| Residency: | Stanford University School of Medicine CA (1996) |
| Board Certification: | Internal Medicine, American Board of Internal Medicine (1996) |
| Board Certification: | ABIM, Critical Care Medicine (1999) |
| Board Certification: | Pulmonary Disease, American Board of Internal Medicine (1998) |
| Fellowship: | University of Colorado School of Medicine CO (1999) |
| BS: | University of Portland, Biology (1987) |
Graduate & Fellowship Program Affiliations
Internet Links
Scientific Focus
Current Research Interests
Our lab focuses primarily on the contribution of the immune response to lung disease. We are specifically examining the contribution of inflammation to the development of pulmonary hypertension. We also study how airway remodeling occurs in transplantation with specific respect to the microvascular circulation and to the initiation of fibroproliferation.
Publications
- Complement-mediated microvascular injury leads to chronic rejection. Adv Exp Med Biol. 2013: 233-46
- Developing better biomarkers for connective tissue disease-associated interstitial lung disease: citrullinated hsp90 autoantibodies in rheumatoid arthritis. Arthritis Rheum. 2013; (4): 864-8
- Targeting complement component 5a promotes vascular integrity and limits airway remodeling. Proc Natl Acad Sci U S A. 2013; (15): 6061-6
- A brief overview of mouse models of pulmonary arterial hypertension: problems and prospects. Am J Physiol Lung Cell Mol Physiol. 2012; (10): L977-91
- Neonatal mice genetically modified to express the elastase inhibitor elafin are protected against the adverse effects of mechanical ventilation on lung growth. Am J Physiol Lung Cell Mol Physiol. 2012; (3): L215-27
- New methods for monitoring dynamic airway tissue oxygenation and perfusion in experimental and clinical transplantation. Am J Physiol Lung Cell Mol Physiol. 2012; (10): L861-9
Help